Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 9Recruiting 2Terminated 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Parasomnias 1Fatigue 1Depression 1Anxiety Disorders 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × OTHER × Ultraviolet Therapy × Clear all
NCT01193530 2019-03-26

The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2/3 Terminated
12 enrolled 3 charts

Anxiety Disorders, Depression, Fatigue, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡